The FDA added a warning to the label of esketamine nasal spray (Spravato), noting that long-term cognitive and memory ...

Learn more about how an anesthetic traditionally used for surgical procedures may help depression and what to expect during ...

Mental health is a vital aspect of overall well-being, especially for students who face unique pressures and challenges. From ...

When Dr. Husseini Manji was developing the first-in-class depression medication Spravato at Johnson & Johnson he encountered plenty of naysayers.

Psychedelics like psilocybin, MDMA, and ketamine are emerging as promising therapeutic tools for mental health issues. Here's ...

If approved, lying in wait for Vraylar in the treatment-resistant depression category will be Johnson & Johnson's Spravato (esketamine), which was approved by the FDA in 2019, albeit with a label ...

Now a sub-study shows that there is also ... Sleeping for 2: Insomnia Therapy Reduces Postpartum Depression, Study Shows Oct. 31, 2024 — CBT for insomnia significantly reduces postpartum ...

most studies of ketamine in depression have relied on either intravenous or intranasal administration, the latter resulting in the approval of J&J’s Spravato (esketamine) for TRD in 2019 and for ...

"I do know some guys that take [es]ketamine for PTSD. It's helped them immensely." Veterans use the nasal spray esketamine to treat mental health conditions such as PTSD, chronic depression, and ...